ALSE

Alseres Pharmaceuticals (CE) (ALSE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ALSE
DataOraFonteTitoloSimboloCompagnia
21/11/201422:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
18/11/201421:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/08/201414:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
16/05/201415:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
10/04/201414:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201423:00Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201423:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320:40Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320:40Edgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/01/201316:21Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/11/201212:08Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
29/03/201222:50Edgar (US Regulatory)Annual Report (10-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/02/201222:11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
27/12/201122:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
27/12/201122:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/06/201122:56Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
03/01/201121:46Edgar (US Regulatory)Amended tender offer statement by Issuer (SC TO-I/A)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/05/201022:53Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
30/04/201016:50Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
10/11/200922:44Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
17/07/200915:31Edgar (US Regulatory)(25-NSE)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ALSE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network